- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
B&L researcher receive highest scientific honor from Shandong Institute
Two Bausch & Lomb executives have received the highest scientific honor from the Shandong Institute of Pharmaceutical Research, being named distinguished research fellows.
Rochester, NY-Two Bausch & Lomb (B&L) executives have received the highest scientific honor from the Shandong Institute of Pharmaceutical Research, being named distinguished research fellows. Recently a ceremony was held for Praveen Tyle, PhD, chief scientific officer, and Erning Xia, research fellow and coordinator for B&L Freda research and development.
The company's pharmaceutical joint venture, B&L Freda, has recently relocated its research to Jinan, China.
"We're proud to be partnering with the Shandong Institute of Pharmaceutical Research for ongoing discovery and development endeavors," said Dr. Tyle. "We're now conducting more global research at the site, and the increased space at the new facility affords us the opportunity to grow as Bausch & Lomb grows."
